Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Miranda Patterson"'
Autor:
Despoina Kaloriti, Mette Jacobsen, Zhikang Yin, Miranda Patterson, Anna Tillmann, Deborah A. Smith, Emily Cook, Tao You, Melissa J. Grimm, Iryna Bohovych, Celso Grebogi, Brahm H. Segal, Neil A. R. Gow, Ken Haynes, Janet Quinn, Alistair J. P. Brown
Publikováno v:
mBio, Vol 5, Iss 4 (2014)
ABSTRACT Immune cells exploit reactive oxygen species (ROS) and cationic fluxes to kill microbial pathogens, such as the fungus Candida albicans. Yet, C. albicans is resistant to these stresses in vitro. Therefore, what accounts for the potent antifu
Externí odkaz:
https://doaj.org/article/4dfb09531b17429f9de94c33d6f04296
Autor:
Terry J. Gaymes, Azim M. Mohamedali, Miranda Patterson, Nazia Matto, Alexander Smith, Austin Kulasekararaj, Rajani Chelliah, Nicola Curtin, Farzin Farzaneh, Sydney Shall, Ghulam J. Mufti
Publikováno v:
Haematologica, Vol 98, Iss 9 (2013)
Inactivation of the DNA mismatch repair pathway manifests as microsatellite instability, an accumulation of mutations that drives carcinogenesis. Here, we determined whether microsatellite instability in acute myeloid leukemia and myelodysplastic syn
Externí odkaz:
https://doaj.org/article/7809fae7515f403ba35031aa086eb364
Autor:
Zev A. Wainberg, Lauren Averett Byers, Nicola J. Curtin, Miranda Patterson, Ashleigh Herriott, Joshua W. Henshaw, David C. Smith, John Heymach, Jasgit Sachdev, Stan Kaye, Saeed Rafii, John Glaspy, Rashmi Chugh, Lida Mina, Ramesh K. Ramanathan, Johann de Bono
Supplementary Figure S1. Talazoparib inhibition of PBMC PARP activity.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36e95db2be5b81e9a0f3ad86b8281bd1
https://doi.org/10.1158/2159-8290.22531110
https://doi.org/10.1158/2159-8290.22531110
Autor:
Zev A. Wainberg, Lauren Averett Byers, Nicola J. Curtin, Miranda Patterson, Ashleigh Herriott, Joshua W. Henshaw, David C. Smith, John Heymach, Jasgit Sachdev, Stan Kaye, Saeed Rafii, John Glaspy, Rashmi Chugh, Lida Mina, Ramesh K. Ramanathan, Johann de Bono
Supplementary Methods includes additional details on these topics: tumors eligible for dose escalation phase; tumors eligible for dose expansion phase; patients enrolled using a local laboratory; study design and participants; additional inclusion cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c35bb32f493e71bbc643b22bb0b3649
https://doi.org/10.1158/2159-8290.22531107.v1
https://doi.org/10.1158/2159-8290.22531107.v1
Autor:
Zev A. Wainberg, Lauren Averett Byers, Nicola J. Curtin, Miranda Patterson, Ashleigh Herriott, Joshua W. Henshaw, David C. Smith, John Heymach, Jasgit Sachdev, Stan Kaye, Saeed Rafii, John Glaspy, Rashmi Chugh, Lida Mina, Ramesh K. Ramanathan, Johann de Bono
Supplementary Table S1. Dose-response and exposure-response parameters.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b99fccdd412f6f65d1dfdcba0f9d8d0
https://doi.org/10.1158/2159-8290.22531104
https://doi.org/10.1158/2159-8290.22531104
Autor:
Claire Kolenda, Carmen Martin-Ruiz, Alastair Greystoke, Claire Hutton, Tim Simmons, Craig Parker, Nicola Wyatt, David Jamieson, P. Mulvenna, Fiona Black, Dianne Turner, Miranda Patterson, Linda Hogarth, Alexander Bradshaw
Publikováno v:
Journal of Thoracic Oncology. 12:S829-S830
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66d5c0817852369b1631b9613b7b49b5
https://doi.org/10.1016/j.jtho.2016.11.1122
https://doi.org/10.1016/j.jtho.2016.11.1122